The Advisory Panel on Rare Disease will advise and provide recommendations to PCORI’s Board of Governors, Methodology Committee, and staff on the conduct of patient-centered comparative clinical effectiveness research in rare diseases and on coordination and engagement with the rare disease research community, including other funders of research on rare diseases and existing infrastructure dedicated to research on rare diseases.

Ad-Hoc Expert Advisory Panels

In the case of a research study for each rare disease, the Rare Disease Advisory Panel shall assist PCORI in identifying experts to serve on a condition-specific ad hoc advisory panel to assist in evaluating, designing and conducting PCORI-funded research and determining the relative value and feasibility of conducting the research study.

Highlighting the Work and Importance of the Advisory Panel on Rare Disease

Aliza Fink, DSc, MS — a member of the PCORI Advisory Panel on Rare Diseases — shares how patient-centered outcomes research and comparative clinical effectiveness research are conducted differently in rare diseases and their importance for patients and families in the rare disease community. 

Posted: November 22, 2013; Updated: September 16, 2022

What's Happening at PCORI?

The Patient-Centered Outcomes Research Institute sends weekly emails about opportunities to apply for funding, newly funded research studies and engagement projects, results of our funded research, webinars, and other new information posted on our site.

Subscribe to PCORI Emails

Image

Hand pointing to email icon